These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Post-seizure EEG fractal dimension of first ECT predicts antidepressant response at two weeks.
    Author: Gangadhar BN, Subbakrishna DK, Janakiramaiah N, Motreja S, Narayana Dutt D, Paramehwara G.
    Journal: J Affect Disord; 1999; 52(1-3):235-8. PubMed ID: 10357038.
    Abstract:
    BACKGROUND: Duration of seizure by itself is an insufficient criterion for a therapeutically adequate seizure in ECT. Therefore, measures of seizure EEG other than its duration need to be explored as indices of seizure adequacy and predictors of treatment response. We measured the EEG seizure using a geometrical method-fractal dimension (FD) and examined if this measure predicted remission. METHODS: Data from an efficacy study on melancholic depressives (n = 40) is used for the present exploration. They received thrice or once weekly ECTs, each schedule at two energy levels - high or low energy level. FD was computed for early-, mid- and post-seizure phases of the ictal EEG. Average of the two channels was used for analysis. RESULTS: Two-thirds of the patients (n = 25) were remitted at the end of 2 weeks. As expected, a significantly higher proportion of patients receiving thrice weekly ECT remitted than in patients receiving once weekly ECT. Smaller post-seizure FD at first ECT is the only variable which predicted remission status after six ECTs. Within the once weekly ECT group too, smaller post-seizure FD was associated with remission status. CONCLUSIONS: Post-seizure FD is proposed as a novel measure of seizure adequacy and predictor of treatment response. CLINICAL IMPLICATIONS: Seizure measures at first ECT may guide selection of ECT schedule to optimize ECT. LIMITATIONS: The study examined short term antidepressant effects only. The results may not be generalized to medication-resistant depressives.
    [Abstract] [Full Text] [Related] [New Search]